{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:49:03Z","timestamp":1787500143647,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bbrc.2025.152650","type":"journal-article","created":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:21:03Z","timestamp":1757859663000},"page":"152650","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Inhibition of BCL-2 and MCL-1 disrupts mitochondrial respiration and overcomes radioresistance in choroidal melanoma"],"prefix":"10.1016","volume":"784","author":[{"given":"Yi","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2025.152650_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12081758","article-title":"Uveal melanoma: comprehensive review of its pathophysiology, diagnosis, treatment, and future perspectives","volume":"12","author":"Kulbay","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbrc.2025.152650_bib2","article-title":"Choroidal melanoma: a mini review","volume":"10","author":"Soliman","year":"2023","journal-title":"Medicines (Basel)"},{"key":"10.1016\/j.bbrc.2025.152650_bib3","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/ICU.0000000000000761","article-title":"Radiation therapy for uveal melanoma: a review of treatment methods available in 2021","volume":"32","author":"Reichstein","year":"2021","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.bbrc.2025.152650_bib4","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/s41419-019-1568-3","article-title":"BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival","volume":"10","author":"Lee","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2025.152650_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12082182","article-title":"Simultaneously inhibiting BCL2 and MCL1 is a therapeutic option for patients with advanced melanoma","volume":"12","author":"Mukherjee","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbrc.2025.152650_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22073730","article-title":"Bcl-2 family of proteins in the control of mitochondrial calcium signalling: an old chap with new roles","volume":"22","author":"Morris","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2025.152650_bib7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s10495-022-01780-7","article-title":"BCL-2 protein family: attractive targets for cancer therapy","volume":"28","author":"Kaloni","year":"2023","journal-title":"Apoptosis"},{"key":"10.1016\/j.bbrc.2025.152650_bib8","doi-asserted-by":"crossref","first-page":"5718","DOI":"10.1038\/s41388-021-01926-y","article-title":"Synergistic melanoma cell death mediated by inhibition of both MCL1 and BCL2 in high-risk tumors driven by NF1\/PTEN loss","volume":"40","author":"He","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2025.152650_bib9","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/j.jid.2021.11.035","article-title":"Expression differences in BCL2 family members between uveal and cutaneous melanomas account for varying sensitivity to BH3 mimetics","volume":"142","author":"Mukherjee","year":"2022","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbrc.2025.152650_bib10","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/030089160108700112","article-title":"Bcl-2 expression in primary uveal melanoma","volume":"87","author":"Sulkowska","year":"2001","journal-title":"Tumori"},{"key":"10.1016\/j.bbrc.2025.152650_bib11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13045-021-01079-1","article-title":"Targeting MCL-1 in cancer: current status and perspectives","volume":"14","author":"Wang","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbrc.2025.152650_bib12","doi-asserted-by":"crossref","first-page":"6209","DOI":"10.1111\/febs.16136","article-title":"Understanding MCL1: from cellular function and regulation to pharmacological inhibition","volume":"289","author":"Sancho","year":"2022","journal-title":"FEBS J."},{"key":"10.1016\/j.bbrc.2025.152650_bib13","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1007\/s12094-022-03070-9","article-title":"Bcl-2 pathway inhibition in solid tumors: a review of clinical trials","volume":"25","author":"Ploumaki","year":"2023","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.bbrc.2025.152650_bib14","doi-asserted-by":"crossref","first-page":"13762","DOI":"10.1021\/acs.jmedchem.0c01234","article-title":"Discovery of S64315, a potent and selective Mcl-1 inhibitor","volume":"63","author":"Szlavik","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.152650_bib15","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.3324\/haematol.2018.212308","article-title":"Preclinical evaluation of the simultaneous inhibition of MCL-1 and BCL-2 with the combination of S63845 and venetoclax in multiple myeloma","volume":"105","author":"Algarin","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.bbrc.2025.152650_bib16","first-page":"294","article-title":"Bcl-2 expression in human melanocytes and melanocytic tumors","volume":"145","author":"van den Oord","year":"1994","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrc.2025.152650_bib17","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/s12967-015-0689-4","article-title":"Bcl-2 confers survival in cisplatin treated cervical cancer cells: circumventing cisplatin dose-dependent toxicity and resistance","volume":"13","author":"Leisching","year":"2015","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbrc.2025.152650_bib18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.canlet.2005.05.039","article-title":"Upregulation of Bcl-2 is associated with cisplatin-resistance via inhibition of bax translocation in human bladder cancer cells","volume":"237","author":"Cho","year":"2006","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2025.152650_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19123950","article-title":"Bcl-2 inhibition to overcome resistance to Chemo- and immunotherapy","volume":"19","author":"Garcia-Aranda","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2025.152650_bib20","doi-asserted-by":"crossref","first-page":"5193","DOI":"10.18632\/oncotarget.6405","article-title":"Bcl-2 family proteins as regulators of cancer cell invasion and metastasis: a review focusing on mitochondrial respiration and reactive oxygen species","volume":"7","author":"Um","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2025.152650_bib21","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.31557\/APJCP.2021.22.7.2191","article-title":"MiRNA-Mediated knock-down of Bcl-2 and Mcl-1 increases fludarabine-sensitivity in CLL-CII cells","volume":"22","author":"Ashofteh","year":"2021","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"key":"10.1016\/j.bbrc.2025.152650_bib22","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1136\/gutjnl-2020-321175","article-title":"Targeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinoma","volume":"70","author":"Song","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.bbrc.2025.152650_bib23","article-title":"Dual targeting of Mcl-1 and Bcl-2 to overcome chemoresistance in cervical and colon cancer","author":"Wang","year":"2023","journal-title":"Anti Cancer Drugs"},{"key":"10.1016\/j.bbrc.2025.152650_bib24","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1038\/s41416-023-02219-9","article-title":"Dual targeting of BCL-2 and MCL-1 in the presence of BAX breaks venetoclax resistance in human small cell lung cancer","volume":"128","author":"Valko","year":"2023","journal-title":"Br. J. Cancer"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2501366X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2501366X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T08:32:38Z","timestamp":1780302758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X2501366X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":24,"alternative-id":["S0006291X2501366X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152650","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of BCL-2 and MCL-1 disrupts mitochondrial respiration and overcomes radioresistance in choroidal melanoma","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152650","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152650"}}